New specification for steviol glycoside under evaluation by FSANZ
Australia
Aug 30, 2021
FSANZ is evaluating approval of a new specification for the steviol glycoside, rebaudioside I, produced by enzymatic bioconversion of stevia leaf extract. Bioconversion enzymes are derived from a genetically modified yeast strain, Pichia pastoris.
For further information (in English), click on the Link
Food Supplements and Food for Specific Groups
UK
Jan 30, 2023
New fees for food and dietary supplement procedures
Argentina
Jan 09, 2023
New business guidance for marketers of health products
USA
Dec 21, 2022
Updated ingredient requirements for dietary supplements
Argentina
Nov 28, 2022
Active ingredients claimed on the label of health supplements
Malaysia
Nov 28, 2022
Use of iodine as a supplemental ingredient in foods
Canada
Nov 11, 2022
Review of the use of nicotinic acid
South Korea
Nov 10, 2022
Brazil - Vitamin C dietary supplement: inspection during adequacy period of new legislation
Brazil
Oct 17, 2022
Foods for special diets, nutritional supplements and probiotics
El Salvador
Oct 03, 2022
Quality requirements for health supplements
Indonesia
Sep 30, 2022
Evaluation of food supplement labels referred to the current Brazilian legislation
Brazil
Sep 29, 2022
Amendment to the list of ingredients used in dietary supplements
Poland
Sep 29, 2022
USA /EU/India/China/Japan - New Regulatory Norms Promulgated for Nutraceuticals and Dietary Supplements to Address the Challenges regarding Its Safety and Efficacy
USA
Sep 27, 2022
Survey on non-compliant health claims in dietary supplements
France
Sep 26, 2022
Around the World - Exploration of facilitators and barriers to the regulatory frameworks of dietary and herbal supplements: a scoping review
USA
Sep 15, 2022
